New U.K. investment trust

New U.K. investment trust

Reabourne was formed in 1995 as a joint venture to invest in life sciences companies in the U.K. and Western Europe, with a focus on biotechnology. Reabourne director Peter Keen co-founded Chiroscience Group plc (LSE:CRO) in 1990 with Chris Evans, who co-founded the Merlin Fund in 1996. Another Reabourne director, John Gordon, spent nine years at British Biotech plc (BBIOY) as the company's research director and served as CEO of BBIOY's Neures Ltd. subsidiary.

CASDIN THE

Read the full 799 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE